Home
Home

off label

Boehringer Ingelheim to pay $95M in settlement

Boehringer Ingelheim to pay $95M in settlement
Wilkes Barr Times-Leader, PA

J. & J. to Pay $158 Million to End Suit Filed by Texas

J. & J. to Pay $158 Million to End Suit Filed by Texas
New York Times

News

Pfizer Ordered to Pay $142.1 Million Over Neurontin `Off-Label' Marketing
Bloomberg

News

Here We Go Again: Novartis Fined for Off-Label Marketing
Seeking Alpha
»

News

Abbott Must Hand Over CEO Emails: Biotech's Latest Trials and Tribulations
Seeking Alpha
»

News

Paxil Off-Label Use to Be Focus of Heart Defects Trial
Lawyers and Settlements
»

News

Pharma Seeks Cure For Off-Label Woes
Yahoo/Investor's Business Daily
»

News

What’s Not Up With Off-Label Use Economic Loss Claims
Drug and Device Law
»